Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis

Figure 1

The expression of hsa-mir-124 was associated with overall survival in breast invasive carcinoma patients. The Cox regression test was performed to investigate the prognostic value of (a) hsa-mir-124-1, (b) hsa-mir-124-2, and (c) hsa-mir-124-3 in BRCA. Annotation: 0 (0 ≤ median, blue), 1 (1 > median, red).

(a)

(b)

(c)